4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-18-000054
Director bought 65,934 shares at $22.75 ($1,499,999)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-01-05 | Purchase : show line 1 in the form | +65,934 | $22.75 | $1,499,999 | 1,887,202 | I |
| Open-market purchases · 65,934 sh · avg $22.75 · $1,499,999 | ||||||
Loading xslF345X03/crisprabefm4_jan52018.xml…